Adjunctive Therapy and Mortality in Patients With Unstable Pulmonary Embolism

Mortality with adjunctive therapy in patients with unstable pulmonary embolism, defined as those in shock or on ventilator support, is sparsely studied and requires further investigation. This was a retrospective cohort study based on administrative data from the Nationwide Inpatient Sample, 2016. I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2020-06, Vol.125 (12), p.1913-1919
Hauptverfasser: Stein, Paul D., Matta, Fadi, Hughes, Patrick G., Hughes, Mary J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1919
container_issue 12
container_start_page 1913
container_title The American journal of cardiology
container_volume 125
creator Stein, Paul D.
Matta, Fadi
Hughes, Patrick G.
Hughes, Mary J.
description Mortality with adjunctive therapy in patients with unstable pulmonary embolism, defined as those in shock or on ventilator support, is sparsely studied and requires further investigation. This was a retrospective cohort study based on administrative data from the Nationwide Inpatient Sample, 2016. In-hospital all-cause mortality in unstable patients with acute pulmonary embolism was assessed according to treatment. Patients were identified by International Classification of Diseases-10-Clinical Modification Codes. Most unstable patients, 85%, received only anticoagulants. Their mortality was 3,080 of 6,635 (46%) without an inferior vena cava (IVC) filter, and mortality was much less with an IVC filter, 285 of 1,185 (24%) (p
doi_str_mv 10.1016/j.amjcard.2020.03.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2408205027</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914920302630</els_id><sourcerecordid>2425667784</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-aceb2c09d98bd159eec43fae3e0246bf36791283a091cdae15bc9bc76bf12fab3</originalsourceid><addsrcrecordid>eNqFkEtLHTEUgEOx1KvtT6gE3HQz05NkXlkVEasFpS6ULkMeZzDDPG6TjHD_vZF77aIbV4fD-c7rI-Qrg5IBa74PpZ4Gq4MrOXAoQZTAqg9kw7pWFkwycUQ2AMALySp5TE5iHHLKWN18IseCVy2ra9iQuws3rLNN_hnpwxMGvd1RPTt6t4SkR5921M_0XiePc4r0j09P9HGOSZsR6f06Tsusw45eTWYZfZw-k4-9HiN-OcRT8vjz6uHyprj9ff3r8uK2sEKKVGiLhluQTnbGsVoi2kr0GgUCrxrTi6aVjHdCg2TWaWS1sdLYNpcY77URp-Tbfu42LH9XjElNPlocRz3jskbFK-g41MDbjJ7_hw7LGuZ8XaZ43TRt21WZqveUDUuMAXu1DX7KrykG6tW3GtTBt3r1rUCo7Dv3nR2mr2ZC96_rTXAGfuwBzDqePQYVbXZp0fmANim3-HdWvAAfMJP2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425667784</pqid></control><display><type>article</type><title>Adjunctive Therapy and Mortality in Patients With Unstable Pulmonary Embolism</title><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central</source><creator>Stein, Paul D. ; Matta, Fadi ; Hughes, Patrick G. ; Hughes, Mary J.</creator><creatorcontrib>Stein, Paul D. ; Matta, Fadi ; Hughes, Patrick G. ; Hughes, Mary J.</creatorcontrib><description>Mortality with adjunctive therapy in patients with unstable pulmonary embolism, defined as those in shock or on ventilator support, is sparsely studied and requires further investigation. This was a retrospective cohort study based on administrative data from the Nationwide Inpatient Sample, 2016. In-hospital all-cause mortality in unstable patients with acute pulmonary embolism was assessed according to treatment. Patients were identified by International Classification of Diseases-10-Clinical Modification Codes. Most unstable patients, 85%, received only anticoagulants. Their mortality was 3,080 of 6,635 (46%) without an inferior vena cava (IVC) filter, and mortality was much less with an IVC filter, 285 of 1,185 (24%) (p &lt;0.0001). Mortality with catheter-directed thrombolysis alone, 70 of 235 (30%), did not differ significantly from mortality with anticoagulants plus an IVC filter, p = 0.07, although a trend favored the latter. Intravenous thrombolytic therapy without an IVC filter showed a mortality of 295 of 695 (42%) which tended to be lower than mortality with anticoagulants alone (p = 0.06). The addition of an IVC filter to intravenous thrombolytic therapy resulted in a mortality of 20 of 165 (12%), which was the lowest mortality with any combination of adjunctive treatments. Intravenous thrombolytic therapy, however, was associated with more adverse effects of therapy than catheter-directed thrombolysis or anticoagulants.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2020.03.014</identifier><identifier>PMID: 32471550</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age ; Anticoagulants ; Catheters ; Embolism ; Intravenous administration ; Medical instruments ; Mortality ; Patients ; Pulmonary embolisms ; Therapy ; Thrombolysis</subject><ispartof>The American journal of cardiology, 2020-06, Vol.125 (12), p.1913-1919</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><rights>2020. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-aceb2c09d98bd159eec43fae3e0246bf36791283a091cdae15bc9bc76bf12fab3</citedby><cites>FETCH-LOGICAL-c393t-aceb2c09d98bd159eec43fae3e0246bf36791283a091cdae15bc9bc76bf12fab3</cites><orcidid>0000-0002-0073-6961 ; 0000-0003-1712-1549</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2425667784?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993,64383,64385,64387,72239</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32471550$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stein, Paul D.</creatorcontrib><creatorcontrib>Matta, Fadi</creatorcontrib><creatorcontrib>Hughes, Patrick G.</creatorcontrib><creatorcontrib>Hughes, Mary J.</creatorcontrib><title>Adjunctive Therapy and Mortality in Patients With Unstable Pulmonary Embolism</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Mortality with adjunctive therapy in patients with unstable pulmonary embolism, defined as those in shock or on ventilator support, is sparsely studied and requires further investigation. This was a retrospective cohort study based on administrative data from the Nationwide Inpatient Sample, 2016. In-hospital all-cause mortality in unstable patients with acute pulmonary embolism was assessed according to treatment. Patients were identified by International Classification of Diseases-10-Clinical Modification Codes. Most unstable patients, 85%, received only anticoagulants. Their mortality was 3,080 of 6,635 (46%) without an inferior vena cava (IVC) filter, and mortality was much less with an IVC filter, 285 of 1,185 (24%) (p &lt;0.0001). Mortality with catheter-directed thrombolysis alone, 70 of 235 (30%), did not differ significantly from mortality with anticoagulants plus an IVC filter, p = 0.07, although a trend favored the latter. Intravenous thrombolytic therapy without an IVC filter showed a mortality of 295 of 695 (42%) which tended to be lower than mortality with anticoagulants alone (p = 0.06). The addition of an IVC filter to intravenous thrombolytic therapy resulted in a mortality of 20 of 165 (12%), which was the lowest mortality with any combination of adjunctive treatments. Intravenous thrombolytic therapy, however, was associated with more adverse effects of therapy than catheter-directed thrombolysis or anticoagulants.</description><subject>Age</subject><subject>Anticoagulants</subject><subject>Catheters</subject><subject>Embolism</subject><subject>Intravenous administration</subject><subject>Medical instruments</subject><subject>Mortality</subject><subject>Patients</subject><subject>Pulmonary embolisms</subject><subject>Therapy</subject><subject>Thrombolysis</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkEtLHTEUgEOx1KvtT6gE3HQz05NkXlkVEasFpS6ULkMeZzDDPG6TjHD_vZF77aIbV4fD-c7rI-Qrg5IBa74PpZ4Gq4MrOXAoQZTAqg9kw7pWFkwycUQ2AMALySp5TE5iHHLKWN18IseCVy2ra9iQuws3rLNN_hnpwxMGvd1RPTt6t4SkR5921M_0XiePc4r0j09P9HGOSZsR6f06Tsusw45eTWYZfZw-k4-9HiN-OcRT8vjz6uHyprj9ff3r8uK2sEKKVGiLhluQTnbGsVoi2kr0GgUCrxrTi6aVjHdCg2TWaWS1sdLYNpcY77URp-Tbfu42LH9XjElNPlocRz3jskbFK-g41MDbjJ7_hw7LGuZ8XaZ43TRt21WZqveUDUuMAXu1DX7KrykG6tW3GtTBt3r1rUCo7Dv3nR2mr2ZC96_rTXAGfuwBzDqePQYVbXZp0fmANim3-HdWvAAfMJP2</recordid><startdate>20200615</startdate><enddate>20200615</enddate><creator>Stein, Paul D.</creator><creator>Matta, Fadi</creator><creator>Hughes, Patrick G.</creator><creator>Hughes, Mary J.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0073-6961</orcidid><orcidid>https://orcid.org/0000-0003-1712-1549</orcidid></search><sort><creationdate>20200615</creationdate><title>Adjunctive Therapy and Mortality in Patients With Unstable Pulmonary Embolism</title><author>Stein, Paul D. ; Matta, Fadi ; Hughes, Patrick G. ; Hughes, Mary J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-aceb2c09d98bd159eec43fae3e0246bf36791283a091cdae15bc9bc76bf12fab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Anticoagulants</topic><topic>Catheters</topic><topic>Embolism</topic><topic>Intravenous administration</topic><topic>Medical instruments</topic><topic>Mortality</topic><topic>Patients</topic><topic>Pulmonary embolisms</topic><topic>Therapy</topic><topic>Thrombolysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stein, Paul D.</creatorcontrib><creatorcontrib>Matta, Fadi</creatorcontrib><creatorcontrib>Hughes, Patrick G.</creatorcontrib><creatorcontrib>Hughes, Mary J.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stein, Paul D.</au><au>Matta, Fadi</au><au>Hughes, Patrick G.</au><au>Hughes, Mary J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adjunctive Therapy and Mortality in Patients With Unstable Pulmonary Embolism</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2020-06-15</date><risdate>2020</risdate><volume>125</volume><issue>12</issue><spage>1913</spage><epage>1919</epage><pages>1913-1919</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>Mortality with adjunctive therapy in patients with unstable pulmonary embolism, defined as those in shock or on ventilator support, is sparsely studied and requires further investigation. This was a retrospective cohort study based on administrative data from the Nationwide Inpatient Sample, 2016. In-hospital all-cause mortality in unstable patients with acute pulmonary embolism was assessed according to treatment. Patients were identified by International Classification of Diseases-10-Clinical Modification Codes. Most unstable patients, 85%, received only anticoagulants. Their mortality was 3,080 of 6,635 (46%) without an inferior vena cava (IVC) filter, and mortality was much less with an IVC filter, 285 of 1,185 (24%) (p &lt;0.0001). Mortality with catheter-directed thrombolysis alone, 70 of 235 (30%), did not differ significantly from mortality with anticoagulants plus an IVC filter, p = 0.07, although a trend favored the latter. Intravenous thrombolytic therapy without an IVC filter showed a mortality of 295 of 695 (42%) which tended to be lower than mortality with anticoagulants alone (p = 0.06). The addition of an IVC filter to intravenous thrombolytic therapy resulted in a mortality of 20 of 165 (12%), which was the lowest mortality with any combination of adjunctive treatments. Intravenous thrombolytic therapy, however, was associated with more adverse effects of therapy than catheter-directed thrombolysis or anticoagulants.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32471550</pmid><doi>10.1016/j.amjcard.2020.03.014</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-0073-6961</orcidid><orcidid>https://orcid.org/0000-0003-1712-1549</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2020-06, Vol.125 (12), p.1913-1919
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_2408205027
source Elsevier ScienceDirect Journals Complete; ProQuest Central
subjects Age
Anticoagulants
Catheters
Embolism
Intravenous administration
Medical instruments
Mortality
Patients
Pulmonary embolisms
Therapy
Thrombolysis
title Adjunctive Therapy and Mortality in Patients With Unstable Pulmonary Embolism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T16%3A10%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adjunctive%20Therapy%20and%20Mortality%20in%20Patients%20With%20Unstable%20Pulmonary%20Embolism&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Stein,%20Paul%20D.&rft.date=2020-06-15&rft.volume=125&rft.issue=12&rft.spage=1913&rft.epage=1919&rft.pages=1913-1919&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2020.03.014&rft_dat=%3Cproquest_cross%3E2425667784%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2425667784&rft_id=info:pmid/32471550&rft_els_id=S0002914920302630&rfr_iscdi=true